Get the Stockscreener App
17.59
0.92%
+0.16
ProShares UltraShort Nasdaq Biotechnology -2x Shares stock is currently priced at $17.59, with a 24-hour trading volume of 1,160.
It has seen a +0.92% increased in the last 24 hours and a -14.49% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $17.43 pivot point. If it approaches the $17.43 resistance level, significant changes may occur.
Previous Close:
$17.43
Open:
$17.56
24h Volume:
1,160
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.51%
1M Performance:
-14.49%
6M Performance:
-27.55%
1Y Performance:
-11.56%
1D Range:
$17.56
$17.60
52W Range:
$16.37
$26.51
ProShares UltraShort Nasdaq Biotechnology -2x Shares Stock (BIS) Company Profile
Name
ProShares UltraShort Nasdaq Biotechnology -2x Shares
Sector
Industry
Phone
866-776-5125
Address
-
ProShares UltraShort Nasdaq Biotechnology -2x Shares Stock (BIS) Latest News
Atria Wealth Solutions Inc. Reduces Holdings in VanEck High Yield Muni ETF (BATS:HYD) - Defense World
Defense World
2 ETFs to Watch for Outsized Volume on Internet & Inverse Leveraged Biotech - Yahoo Movies Canada
Yahoo Movies Canada
CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF) Short Interest Up 144.4% in March - Defense World
Defense World
ProShares draws record inflows as investors bet on volatility - Financial Times
Financial Times
3 “Oversold” ETFs to Start the Week - ETFdb.com
ETFdb.com
2021 Year in Review: Swelling the Ranks of the Nasdaq Biotechnology Index™ - Nasdaq
Nasdaq
ProShares UltraShort Nasdaq Biotechnology -2x Shares Stock (BIS) Financials Data
There is no financial data for ProShares UltraShort Nasdaq Biotechnology -2x Shares (BIS). Check out other stocks for more information.
About ProShares UltraShort Nasdaq Biotechnology -2x Shares
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
0.27%
0.02%
Cap:
|
Volume (24h):